Alan Jackson’s farewell to the stage is not simply a planned retirement—it is the result of a long, quiet battle with a disease that has gradually changed the way he lives and performs.
Country legend Alan Jackson revealed in 2021 that he has been living with Charcot-Marie-Tooth disease, a rare inherited neurological disorder he was diagnosed with around 2010 but kept private for years. The condition, which also affected his father, grandmother, and sister, has no known cure.
Charcot-Marie-Tooth disease is a degenerative nerve disorder that leads to progressive muscle weakness, reduced sensation in the limbs, and increasing difficulty with balance and coordination. Over time, it can make even basic movement more challenging—something Jackson has openly acknowledged as it began to affect his stage performances.
Speaking with Jenna Bush Hager during a TODAY show interview, Jackson admitted:
“I know I’m stumbling around on stage. And now I’m having a little trouble balancing, even in front of the microphone, and so I just feel very uncomfortable.”
Despite the challenges, Jackson has emphasized that the condition is not life-threatening—but it has changed his ability to perform at the level he expects of himself. In reflecting on his journey, he said:
“It’s been a long road and it’s taken me places I never imagined.”
As he prepares for his farewell concert on June 27, the moment carries a deeper meaning for fans. Reports indicate that a portion of ticket proceeds will go toward the CMT Research Foundation, supporting efforts to better understand and treat the disease that has shaped his final chapter on stage.
For an artist who built a career on timeless storytelling and authenticity, this farewell is not just an ending—it is a reminder of resilience, legacy, and the reality behind the spotlight.